Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
PLoS One. 2019 Mar 22;14(3):e0214415. doi: 10.1371/journal.pone.0214415. eCollection 2019.
This study investigated the significance of change in neutrophil-to-lymphocyte ratio (NLR) during preoperative chemoradiotherapy (preop-CRT) in patients with non-metastatic rectal cancer using a propensity score matching method (PSM).
Patients who underwent surgery after completion of preop-CRT for non-metastatic rectal cancers from Jan 2004 to Dec 2013 were retrospectively enrolled. NLRs were obtained before commencement of CRT (pre-NLR) and between completion of CRT and surgery (post-NLR). Using Cox regression hazards models, the association of NLRs with survival after PSM was examined.
A total of 131 patients were grouped as follows: group A, pre-NLR < 3 & post-NLR < 3 (n = 47); group B, pre-NLR < 3 & post-NLR ≥ 3 (n = 45); group C, pre-NLR ≥ 3 & post-NLR < 3 (n = 5); group D, pre-NLR ≥ 3 & post-NLR ≥ 3 (n = 34). There was no difference in disease-free survival (DFS) or overall survival (OS) rate according to group. When dichotomized into group A versus groups B-D, DFS was higher in group A (84.7%) than groups B-D (67.5%, p = 0.021). After PSM (n = 94), multivariable analysis identified persistent lower NLR as an independent favorable prognosticator of DFS (HR 0.37, 95% CI 0.15-0.92, p = 0.033).
Persistent non-inflammatory state measured by NLR may be an indicator of decreased risk of recurrence in patients with locally advanced rectal cancer treated with preop-CRT.
本研究采用倾向评分匹配法(PSM)探讨非转移性直肠癌患者术前放化疗(preop-CRT)期间中性粒细胞与淋巴细胞比值(NLR)变化的意义。
回顾性纳入 2004 年 1 月至 2013 年 12 月期间接受 preop-CRT 治疗的非转移性直肠癌患者。在 CRT 开始前(pre-NLR)和 CRT 完成与手术之间获得 NLR。使用 Cox 回归风险模型,检查 NLR 与 PSM 后生存的相关性。
共有 131 例患者被分为以下 4 组:A 组,pre-NLR<3 且 post-NLR<3(n=47);B 组,pre-NLR<3 且 post-NLR≥3(n=45);C 组,pre-NLR≥3 且 post-NLR<3(n=5);D 组,pre-NLR≥3 且 post-NLR≥3(n=34)。各组之间无无疾病生存率(DFS)或总生存率(OS)差异。将患者分为 A 组与 B-D 组时,A 组(84.7%)的 DFS 高于 B-D 组(67.5%,p=0.021)。在 PSM(n=94)后,多变量分析发现持续较低的 NLR 是 DFS 的独立预后因素(HR 0.37,95%CI 0.15-0.92,p=0.033)。
NLR 测量的持续非炎症状态可能是接受 preop-CRT 治疗的局部晚期直肠癌患者复发风险降低的指标。